298 related articles for article (PubMed ID: 9726717)
21. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group.
Faurschou P; Steffensen I; Jacques L
Eur Respir J; 1996 Sep; 9(9):1885-90. PubMed ID: 8880107
[TBL] [Abstract][Full Text] [Related]
22. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
Nielsen LP; Pedersen B; Faurschou P; Madsen F; Wilcke JT; Dahl R
Respir Med; 1999 Dec; 93(12):863-8. PubMed ID: 10653047
[TBL] [Abstract][Full Text] [Related]
23. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
Simons FE; Gerstner TV; Cheang MS
Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940
[TBL] [Abstract][Full Text] [Related]
24. Potential masking effects of salmeterol on airway inflammation in asthma.
Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
[TBL] [Abstract][Full Text] [Related]
25. Acute bronchodilatory effect of salmeterol on methacholine-induced bronchoconstriction in childhood asthma.
Baki A; Karagüzel G
Acta Paediatr Jpn; 1998 Apr; 40(2):135-7. PubMed ID: 9581303
[TBL] [Abstract][Full Text] [Related]
26. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
Derom EY; Pauwels RA; Van der Straeten ME
J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164
[TBL] [Abstract][Full Text] [Related]
27. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Murray JJ; Church NL; Anderson WH; Bernstein DI; Wenzel SE; Emmett A; Rickard KA
Allergy Asthma Proc; 1999; 20(3):173-80. PubMed ID: 10389550
[TBL] [Abstract][Full Text] [Related]
28. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
[TBL] [Abstract][Full Text] [Related]
29. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
30. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
Vermetten FA; Boermans AJ; Luiten WD; Mulder PG; Vermue NA
J Asthma; 1999; 36(1):97-106. PubMed ID: 10077139
[TBL] [Abstract][Full Text] [Related]
31. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
[TBL] [Abstract][Full Text] [Related]
32. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
[TBL] [Abstract][Full Text] [Related]
33. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.
Kelsen SG; Church NL; Gillman SA; Lanier BQ; Emmett AH; Rickard KA; Anderson WH
J Asthma; 1999 Dec; 36(8):703-15. PubMed ID: 10609625
[TBL] [Abstract][Full Text] [Related]
34. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
[TBL] [Abstract][Full Text] [Related]
35. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
38. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
[TBL] [Abstract][Full Text] [Related]
39. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.
van der Woude HJ; Aalbers R
Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283
[TBL] [Abstract][Full Text] [Related]
40. Sustained protection against distilled water provocation by a single dose of salmeterol in patients with asthma.
Bootsma GP; Dekhuijzen PN; Festen J; Lammers JW; Mulder PG; van Herwaarden CL
Eur Respir J; 1997 Oct; 10(10):2230-6. PubMed ID: 9387945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
